Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study

Table 5 ANOVA results of main pharmacokinetic parameters in the fed group

Dependent variable	Subject		Treatment		Period		Preparation
Dependent variable	F ^a	P ^b	F	P	F	P	F	P
LnC_max	6.49	*0.0000*	0.01	0.9110	1.22	0.2819	1.08	0.3101
LnAUC_0–t	13.50	*0.0000*	0.11	0.7425	4.91	*0.0373*	0.01	0.9302
LnAUC_0–∞	15.68	*0.0000*	0.04	0.8485	3.51	0.0745	0.01	0.9404

ISSN: 2050-6511